Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 147.11M P/E - EPS this Y 26.30% Ern Qtrly Grth -
Income -75.52M Forward P/E -1.98 EPS next Y - 50D Avg Chg 6.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -43.00%
Dividend N/A Price/Book 1.71 EPS next 5Y - 52W High Chg -81.00%
Recommedations 2.00 Quick Ratio 4.80 Shares Outstanding 256.50M 52W Low Chg 30.00%
Insider Own 1.45% ROA -53.07% Shares Float 252.38M Beta 3.68
Inst Own 10.34% ROE -98.28% Shares Shorted/Prior 36.65M/23.71M Price 0.57
Gross Margin - Profit Margin - Avg. Volume 7,785,711 Target Price 6.33
Oper. Margin - Earnings Date Mar 27 Volume 3,810,886 Change -5.14%
About Ocugen, Inc.

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 and OCU410ST for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. It has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Ocugen, Inc. News
03/18/24 Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer
03/13/24 Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410
03/07/24 Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
03/06/24 Ocugen to Present at Investing in Cures Summit
08:00 AM Ocugen Clinical Showcase Webcast Now Available
02/26/24 Meme Stock Meltdowns: 3 Names to Sell Before They Crash
02/26/24 Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit
02/22/24 Ocugen, Inc. Announces Dosing Completion of Subjects with Stargardt in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST
02/21/24 Ocugen to Present at 2024 BIO CEO & Investor Conference
02/14/24 Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
01/31/24 Ocugen to Present at Pharma Market Research Conference
01/16/24 Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board
12/21/23 Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design
12/19/23 Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations
12/13/23 Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410—Modifier Gene Therapy—for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
11/29/23 Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
11/10/23 Ocugen, Inc. (NASDAQ:OCGN) Q3 2023 Earnings Call Transcript
11/10/23 Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease
11/10/23 Q3 2023 Ocugen Inc Earnings Call
11/09/23 Ocugen (OCGN) Q3 2023 Earnings Call Transcript
OCGN Chatroom

User Image Binno Posted - 2 minutes ago

User Image 9long Posted - 3 minutes ago

$OCGN And people forget all the connections, like Michael Shine formerly serving as the Chief Marketing Officer of Thomas Reuters

User Image 9long Posted - 5 minutes ago

$OCGN If someone would have told me a month ago that we would be holding strong at $1.75 I would have been elated

User Image Fox1Fox2 Posted - 8 minutes ago

$OCGN Anyone else notice Shankcar's body language: (When someone opens their legs, it's a sign they're comfortable, confident, and staking their territory) and his big grin! If they aren't bullish signs....

User Image 9long Posted - 9 minutes ago

$OCGN Partnerships mean when each party wins we are all winners. That's why people like Shanky and Bob Smith and Connie are working Diligently.... it's because they aren't like the greedy Pfizer leeches

User Image 9long Posted - 13 minutes ago

$OCGN Stock market closed tomorrow! Looks like we will have to wait until Monday for a juicy April Fool's PR

User Image SPOON03 Posted - 14 minutes ago

$OCGN 🛒🛒🛒 better late than never 🤷🏽‍♂️

User Image 2TrustHim Posted - 17 minutes ago

$OCGN Look At The Short Interest!!! Could this RUN WILD with a SQUEEZE???!!!

User Image Montna_Js_Back Posted - 17 minutes ago

$OCGN 🐜🐜🚀👇

User Image 9long Posted - 18 minutes ago

$OCGN

User Image TickerM Posted - 18 minutes ago

$OCGN

User Image 9long Posted - 19 minutes ago

$OCGN Geesh, how much longer do we have to wait??? C'mon Bobby and Connie

User Image 9long Posted - 23 minutes ago

$OCGN Just like Mr Wonderful, "I just need to know how I'll get my money back"

User Image MerlinSbeard_ Posted - 24 minutes ago

$OCGN

User Image JonnyWalker007 Posted - 28 minutes ago

$OCGN

User Image scissorhandzz Posted - 28 minutes ago

$OCGN will beat earnings.

User Image Tomassso Posted - 29 minutes ago

$OCGN maybe need some sort of info for Ocugen soon: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-gets-750-mln-funding-blackstone-life-sciences-develop-flu-shots-2024-03-27/

User Image kil0gho5t Posted - 32 minutes ago

$OCGN when this tanks on earnings pumpers will say know what you hold its all part of the plan they want your shares … just like on every other shit ticker 🤣

User Image scissorhandzz Posted - 38 minutes ago

$OCGN what time does the money machine get turned on

User Image Bond_James_Bond000 Posted - 38 minutes ago

$OCGN 📉 i buy more on the low. 📈 i still buy more

User Image JLMNAVY Posted - 42 minutes ago

$VXRT $OCGN Up 10% today Premarket? I hope this is OCGN type of run or better. News about BARDA funding? Giggity giggity!

User Image AnchorMB Posted - 44 minutes ago

$OCGN Happy Thursday! Happy Baseball Opening Day in Cincinnati !Happy OCGN Day! It’s going to be a Homerun!!!

User Image Tomassso Posted - 47 minutes ago

$OCGN shorts have to pay more in fees for the long weekend, for the shares their borrow... Good luck

User Image Tomassso Posted - 48 minutes ago

$OCGN hopefully lots of money around today, going places... Last day to trade this month, do business, investment, spending... For some companies, end of tax year and personal tax year in the UK etc

User Image Stephen_the_Great_18 Posted - 53 minutes ago

$OCGN

User Image tradercool Posted - 56 minutes ago

$OCGN I thought we were under “trading halted” status 🤣🤣🤣 but no! Some rebellious shorters sell a few shares before having to sell their own house with their wife and children in it 🤣🤣🤣.

User Image Ehtaatavaraa Posted - 1 hour ago

$OCGN Did you bears get good night sleep or did you stay up? 😂

User Image Gawgaboi Posted - 1 hour ago

$OCGN

User Image Coolbox Posted - 1 hour ago

$OCGN 1.72 is Waiting zone

User Image Coolbox Posted - 1 hour ago

$OCGN

Analyst Ratings
HC Wainwright & Co. Buy Feb 22, 24
HC Wainwright & Co. Buy Jan 24, 24
Cantor Fitzgerald Overweight Aug 31, 23
HC Wainwright & Co. Buy Aug 23, 23
Chardan Capital Buy May 8, 23
HC Wainwright & Co. Buy Apr 17, 23
Chardan Capital Buy Apr 14, 23
Chardan Capital Buy Mar 1, 23
Mizuho Buy Mar 1, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Musunuri Shankar Chief Executive Offi.. Chief Executive Officer Jan 17 Sell 1.28 100,000 128,000 2,227,950 01/19/23
Musunuri Shankar Chief Executive Offi.. Chief Executive Officer Jan 17 Option 0.51 100,000 51,000 2,327,950 01/19/23
Kumar Ramesh Director Director Apr 18 Option 0.51 7,500 3,825 7,500 04/20/22
Kumar Ramesh Director Director Apr 18 Sell 2.83 7,500 21,225 04/20/22
Zhang Junge Director Director Mar 03 Option 1.17 88,000 102,960 88,000 03/04/22
Musunuri Shankar Chief Executive Offi.. Chief Executive Officer Feb 14 Option 0.33 90,000 29,700 842,540 02/16/22
Musunuri Shankar Chief Executive Offi.. Chief Executive Officer Feb 14 Sell 3.74 90,000 336,600 752,540 02/16/22
Potti Manish Director Director Dec 16 Option 1.17 45,000 52,650 45,000 12/17/21
Kompella Uday Director Director Nov 01 Sell 15.03 50,000 751,500 154,416 11/03/21
Musunuri Shankar Chief Executive Offi.. Chief Executive Officer Nov 01 Option 0.51 115,367 58,837 521,367 11/03/21
Musunuri Shankar Chief Executive Offi.. Chief Executive Officer Nov 01 Sell 14.15 115,367 1,632,443 406,000 11/03/21
Kompella Uday Director Director Oct 18 Sell 8.72 201,731 1,759,094 277,685 10/20/21
Kumar Ramesh Director Director Oct 18 Option 0.51 7,500 3,825 7,500 10/20/21
Kumar Ramesh Director Director Oct 18 Sell 8.13 7,500 60,975 10/20/21
Kompella Uday Director Director Jul 30 Option 1.83 10,000 18,300 560,674 07/30/21